![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Low Incidence of Hyperbilirubinaemia With Ombitasvir-ABT-450/r and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Patients
|
|
|
Reported by Jules Levin
Presented at the American College of Gastroenterology Annual Scientific Meeting, October 17-22, 2014, Philadelphia, Pennsylvania, United States
David Bernstein1, Naoky Tsai2, Tarek Hassanein3, Federico Rodriguez-Perez4, Manuel Romero-Gomez5, Rui Tato Marinho6, Ramon Planas Vila7, Massimo G Colombo8, Sandra Lovell9, Jeff rey V Enejosa9, Yan Luo9, Daniel E Cohen9, Marcos Pedrosa9, K Rajender Reddy10
1Hofstra North Shore-LIJ School of Medicine, Manhasset, New York, United States; 8The Queen's Medical Center - Liver Center, Honolulu, Hawaii, United States; 3Southern California Liver Centers and Southern California Research Center, Coronado, California, United States; 4Gastroenterology and Hepatic Wellness Center, Santurce, Puerto Rico;
5Hospital Universitario Nuestra Senora De Valme, Seville, Spain; 6Centro Hospitalar Lisboa Norte, Medical School of Lisbon, Lisbon, Portugal; 7Hospital Germans TrķasiPujol, CIBERehd, Badalona, Spain; 8University of Milan, Milan, Italy; 9AbbVie Inc., North Chicago, Illinois, United States; 10University of Pennsylvania, Philadelphia, Pennsylvania, United States
![ACG1.gif](../images/102014/102014-3/ACG1.gif)
![ACG2.gif](../images/102014/102014-3/ACG2.gif)
![ACG3.gif](../images/102014/102014-3/ACG3.gif)
![ACG4.gif](../images/102014/102014-3/ACG4.gif)
![ACG5.gif](../images/102014/102014-3/ACG5.gif)
![ACG6.gif](../images/102014/102014-3/ACG6.gif)
![ACG7.gif](../images/102014/102014-3/ACG7.gif)
![ACG8.gif](../images/102014/102014-3/ACG8.gif)
![ACG9.gif](../images/102014/102014-3/ACG9.gif)
![ACG10.gif](../images/102014/102014-3/ACG10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|